Singapore-based ChemLex raised $45 million to build out its autonomous chemistry lab with hopes it can speed drug discovery and therapy development for pharmaceutical and biotechnology companies. The self-driving lab consists of AI software and robots that design experiments, run them, and gather data, according to the company. The facilities run all day, everyday, with limited human intervention.The technology represents what many executives and government leaders are painting as the ideal fut...